Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
Baylor College of Medicine
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Children's Oncology Group
Ann & Robert H Lurie Children's Hospital of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sellas Life Sciences Group
University of Virginia
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
City of Hope Medical Center
Children's Oncology Group
University of South Florida
Dana-Farber Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Children's Oncology Group
Sumitomo Pharma America, Inc.
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Children's Oncology Group
Fred Hutchinson Cancer Center
Columbia University
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center